Loading…
Wednesday, December 1 • 9:45am - 10:30am
Panel: Leadership Perspectives on Prioritizing R&D Investment Through Strategic Portfolio/Pipeline Planning

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Understand the decision-making process behind funding development programs, which clinical indications to pursue and when to kill them
  • Discover how to allocate capital and determine what level of resources to invest to projects that are in different stages of development
  • Determine when to dedicate resources at different stages throughout the process
  • Enhance project prioritization and portfolio optimization activities

Speakers
avatar for Nidhi Shrivastav

Nidhi Shrivastav

Senior Director, Portfolio Strategy and Management, Takeda
Nidhi Shrivastav is the Senior Director, Strategy and Portfolio Management Lead for the gastrointestinal therapeutic area at Takeda Pharmaceutical Company Limited. She is responsible for the coordination, implementation, and prioritization of the portfolio strategy activities for... Read More →
avatar for Leonie Meima, MBA

Leonie Meima, MBA

Executive Director, Lifecycle Lead Immuno-Oncology; Portfolio and Corporate Strategy, Coherus BioSciences
Leonie is a biopharma industry veteran with 20+ years of experience in New Product Planning, Portfolio Planning, and Business Development gained at companies ranging in size from Roche Pharmaceuticals to two scientists and a molecule. Additionally, she spent many years in R&D at Genentech... Read More →
avatar for Sarah Kurz

Sarah Kurz

EVP, Chief Commercialization Officer & Head of Medical Affairs, Partner Therapeutics, Inc.
Sarah is passionate about great science and terrific teams.  She chairs the Executive Team of privately held Partner Therapeutics where she also leads the Commercial and Medical Affairs functions and oversees all corporate planning.  Prior to joining PTx, Sarah served as Vice President... Read More →


Wednesday December 1, 2021 9:45am - 10:30am EST